115816-16-5

Basic information

• Product Name: N₆-((1-phenylcyclohexyl)methyl)adenosine
• Synonyms: N₆-((1-phenylcyclohexyl)methyl)adenosine
• CAS NO: 115816-16-5
• Molecular Weight: 439.514
• Mol File: 115816-16-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N₆-((1-phenylcyclohexyl)methyl)adenosine(CAS DataBase Reference)
• NIST Chemistry Reference: N₆-((1-phenylcyclohexyl)methyl)adenosine(115816-16-5)
• EPA Substance Registry System: N₆-((1-phenylcyclohexyl)methyl)adenosine(115816-16-5)

Safety Data

• Hazardous Substances Data: 115816-16-5(Hazardous Substances Data)

Upstream product

• 17380-54-0 1-amino-2-phenyl-2,2-pentamethyleneethane 
• 2004-06-0 6-Chloropurine riboside 

Relevant articles and documents

N6 -substituted adenosines

The present inventions are novel N6 -substituted adenosines wherein the N substituent is STR1 wherein Ar is an unsubstituted or substituted (1) phenyl, (2) 1- or 2-naphthalenyl, (3) 2- or 3-thienyl, (4) 2- or 3-furanyl, (5) 2-, 4-, or 5-thiazyl, (6) 2-, 3-, or 4-pyridyl, or (7) 2-pyrimidyl wherein the substituents include at least one of lower alkyl, halo, trifluoromethyl, hydroxy, lower alkoxy, lower acyloxyamino, N-lower monoalkyl or N,N-lower dialkylamino, lower thioalkyl, lower alkylsulfonyl, or nitro and R' is hydrogen or alkyl, A is STR2 wherein q, q', or q" are one to four, n and m are independently zero to three provided if A is a bond then n and m is at least 2 and if A is other than a bond then n and m is at least one. These novel adenosines have highly desirable central nervous system and cardiovascular activities and therefore the present invention also includes pharmaceutical compositions and methods of use therefor.